Prevention of no flow/slow reflow phenomenon in primary PCI by nicorandil

Indian Heart Journal

Volumn 59, Issue 3, 2007, Pages 246-249

  Ezhilan, J ^a   Juneja, Manjeet S ^a   George, Thomas ^a   Ramkumar, S R ^a   Viswanathan, V ^a   Badrinath, A K ^a   Kalyani, S ^a   Pandurangi, Ulhas M ^a   Latchumanadhas, K ^a   Mullasari Ajit, S ^a  

^a INSTITUTE OF CARDIOVASCULAR DISEASES   (India)

Author keywords

Nicorandil; No flow slow reflow phenomenon; Primary PCI

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; NICORANDIL; POTASSIUM;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOKALEMIA; HYPOTENSION; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROPHYLAXIS; STENT; THROMBOSIS; THROMBUS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NICORANDIL; REGIONAL BLOOD FLOW; STENTS; VASODILATOR AGENTS;

EID: 36349001900     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Kloner RA, Ganote CE, Jennings RB. The no-reflow phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
2. Ames A 111, Wright RL, Kowada M et al. The no-reflow phenomenon. Am J Pathol 1968;52:437-47.
3. Abbo KM, Dooris M, Glazier S, et al. Features and outcome of no-reflow after percutaneous coronary intervention. Am J Cardiol 1995;75:776-782.
4. Leopald JA, Berger JC, Cuppels LA, et al. No-reflow during coronary interventions: observations and implications. Circulation 2000;102(suppl2):644.
5. Markham A, Plosker GL, Goa KL. Nicorandil: An updated review of its use in ischemic heart disease with emphasis on its cardioprotective effects. Drugs 2000 Oct;60(4):955-74.
6. Morishima I, Sone T, Okumura K, et al. Angiographic Noreflow phenomenon as a predictor of adverse long term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36(4):1202-9.
7. Reffelmann T, Kloner RA. The "No-reflow" phenomenon: Basic science and clinical correlates. Heart 2002;87:162-168.
8. Wang H-J, Lo P-H, Lin J-J, et al. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for Acute myocardial infarction. Catheter Cardiovasc Interv 2004;63:171-176.
9. Ikeda N, Yasu T, Kubo N et al. Nicorandil versus isosorbide dinitrate as adjunctive treatment to direct balloon angioplasty in acute myocardial infarction. Heart 2004;90: 181-185.